Louisiana State University

LSU Digital Commons
Faculty Publications

Department of Biological Sciences

9-23-1985

Locus-specific detection of HLA-DQ and -DR antigens by
antibodies against synthetic N-terminal octapeptides of the β
chain
Thomas Deufel
Hagedorn Research Institute

Anne Grove
Hagedorn Research Institute

Hans Kofod
Hagedorn Research Institute

Åke Lernmark
Hagedorn Research Institute

Follow this and additional works at: https://digitalcommons.lsu.edu/biosci_pubs

Recommended Citation
Deufel, T., Grove, A., Kofod, H., & Lernmark, Å. (1985). Locus-specific detection of HLA-DQ and -DR
antigens by antibodies against synthetic N-terminal octapeptides of the β chain. FEBS Letters, 189 (2),
329-337. https://doi.org/10.1016/0014-5793(85)81050-4

This Article is brought to you for free and open access by the Department of Biological Sciences at LSU Digital
Commons. It has been accepted for inclusion in Faculty Publications by an authorized administrator of LSU Digital
Commons. For more information, please contact ir@lsu.edu.

Volume 189, number 2

FEBS 2821

September 1985

Locus-specific detection of HLA-DQ and -DR antigens by
antibodies against synthetic N-terminal octapeptides of the
Phc ain
Thomas Deufel, Anne Grove, Hans Kofod and Ake Lernmark
Hagedorn Research Laboratory,

Niels Steensensvej 6, DK-2820 Gentofte, Denmark

Received 26 June 1985
Abstract not received.
Antibodies against synthetic peptides representing the class-II antigen HLA-DR and -DQ /l chain N-terminal sequences were prepared in rabbits. The two octapeptides only share two amino acids and enzyme-linked
immuno-assays showed the antisera only to bind to its own antigen. Both peptide antisera detected a 29
kDa component in immunoblots of Raji and AL-34 cell plasma membrane proteins separated by SDS gel
electrophoresis. The binding of either N-terminal peptide antiserum was selectively inhibited only by the
peptide used as antigen. Indirect immunofluorescence.analysis
by flow cytofluorometry showed specific surface immunofluorescence in 1: 100-l : loo0 dilutions in lymphoblastoid and blood mononucleated cells. In
the latter the binding was primarily confined to monocytes and a subpopulation of lymphocytes. It is concluded that locus-specific immunological reagents to distinguish between fi chains of HLA-DR and -DQ
have been prepared by the preparation by the production of antibodies against the N-terminal sequences
of each polypeptide
HLA class II antigen

Flow cytofuorometry

1. INTRODUCTION

HLA class II antigens are structurally
closely
related,
highly polymorphic,
heterodimeric
proteins consisting of an CYchain (Mr 35000) and a p
chain (Mr 29000) [1,2]. The class II antigens are
primarily expressed on the surface of cells important to the immune response [3]. The genes encoding for these antigens are part of the major
histocompatibility complex (MHC) located on the
short arm of chromosome 6. Serologic studies indicate the existence of at least 3 distinct loci, DP,
DQ, and DR [3], and more recent molecular cloning studies have revealed the presence of several cz
and ,8 chain genes at each locus [4].
Little is known about the differences in expression and function of these different gene loci.
These problems are difficult to investigate and re-

ELISA

Immunoblotting

quire immunologic reagents able to distinguish
products of the different loci, as well as the
subspecificities due to allelic variation within one
locus. The extensive sequence homology between
all the class II antigens makes it difficult to obtain
monospecific antibodies [5-71. We have therefore
used
against
antibodies
synthetic
peptides
representing different parts of HLA class II ,8
chains to detect binding to the surface of immune
competent
cells. Antibodies to synthetic intramolecular amino acid sequences are successfully
employed to obtain antibodies with a predetermined specificity against a variety of antigens [S].
Such antibodies may even detect variation in sequences contained within large homologous but
polymorphic polypeptides, such as the rat thy-l
[9], and human MHC Class I [lo] and Class II
[11,12] antigens. The advantage of this technique
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shown [5-7,13-151 to be common to DQ and DR
,f3 chains, respectively. Both peptides were synthesized by Cambridge Res. Biochem. Ltd, Cambridge, England and the sequence confirmed by sequence analysis (Gas Microsequenator,
Applied
Biosystems, Foster City, CA). The peptides were
coupled to porcine thyroglobulin (PTG) (Sigma,
St. Louis, MO) using difluorodinitrobenzene
[ 181.
New Zealand white rabbits were injected intracutaneously at multiple sites with 1 mg antigen
in complete Freund’s adjuvant, and then given 3
booster injections every other week with 0.5 mg in
incomplete
Freund’s adjuvant,
and then at
monthly intervals. Blood was sampled 5-7 days
after each booster injection.

is that antibodies can be produced against proteins

not yet isolated and purified, but predicted from
the nucleotide sequence of cloned genes whether
genomic or complementary to mRNA molecules.
Analysis of published amino acid sequences of
HLA class II ,& chains obtained from protein sequencing [13], or predicted from cloned genomic
or cDNA [5-7,14,15] revealed the N-terminal sequences of DQ and DR ,f3chains to be highly conserved for each locus. Since only 2 out of the first
8 amino acids are shared, we chose these 2 octapeptides to produce locus specific antisera to
detect binding of HLA-DQ and -DR fl chains on
the surface of living cells. Our results demonstrate
that rabbit antisera against either peptide bound to
the surface of living cells and detected a component of Mr 29000 by immunoblotting
[16] of
denatured
components
in plasma membrane
preparations of cells known to express Class II
antigens.
2. MATERIALS
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AND METHODS

2.1. Cells
The lymphoblastoid cell lines Raji and AL-34,
established following EBV transformation of lymphocytes from an HLA-DR 3/4 positive patient
with insulin-dependent diabetes by H. Vissing,
were cultured in RPM1 1640 medium containing
10% (v/v) fetal calf serum. Human peripheral
blood mononuclear cells were isolated by FicollPaque density centrifugation
[17] from blood
donated
by healthy volunteers,
or recently
diagnosed insulin-dependent (type 1) diabetic patients in good metabolic control.
2.2. Peptides and immunization
The peptides DQ(l-8) and DR( 1-8) (table 1)
represent the N-terminal amino acid sequences

2.3. ELBA
Microtiter plates (NUNC, Roskilde, Denmark)
were coated with 2 pg/well of peptides DQ( l-8)
and DR(l-8),
respectively, and blocked with
0.01% (w/v) bovine insulin in phosphate-buffered
saline (PBS). Sera were diluted (1: 1000-l : 50000)
in PBS containing 0.01% insulin and 0.05%
Tween 20. The plates were incubated at 37°C for
2 h first with rabbit serum and then with an f(ab)z
goat anti-rabbit immunoglobulin-peroxidase
conjugate (Tago, Burlingame, CA) second antibody,
diluted 1: 2500 in PBS with insulin and Tween. The
plates were washed 3 times in PBS containing insulin and in distilled water, respectively, prior to
and after incubation with the second antibody.
Peroxidase
activity
was detected
at room
temperature
with 0.4 g/l o-phenylenediamine
(Sigma) and 0.03% hydrogen peroxide in 50 mM
citrate-phosphate
(pH 5.0). The absorbance at
490 nm, automatically subtracted with that at
600 nm, was read on an ELISA reader (Dynatech,
Alexandria, VA). A standard antiserum for each
peptide was analyzed, diluted 1: 5000, on each

Table 1
HLA
antigen

Carrier

DQ(l-8)
DR(l-9)

PTG
PTG

Sequence
-Arg-Asp-Ser-Pro-Glu-Asp-Phe-Val
-Gly-Asp-Thr-Arg-Pro-Arg-Phe-Leu

Rabbit
no.
1828,1829
1789,179O

HLA-DQ and -DR N-terminal sequences were synthesized and
coupled to porcine thyroglobulin (PTG) with the N-terminal reagent
difluorodinitrobenzene
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plate to correct for interassay variation. Results
are expressed as absorption at 490 nm. Nonspecific
binding
to non-coated
wells was
subtracted.
2.4. Flow cytofluorometry on living cells
Cells were washed once and resuspended in PBS
containing 1% BSA and 5 mM sodium azide
(PBS/BSA/NaNs
buffer). Rabbit antisera were
also diluted in this type of medium and incubated
for 1 h at 4°C with 0.5 x lo6 cells per tube in a
final volume of 0.2 ml. The cells were washed by
centrifugation (150 x g, 5 min) in 2.5 ml buffer
and resuspended gently in 0.1 ml FITC-labelled
goat anti-rabbit immunoglobulin
serum (Tago,
Burlingame, CA) diluted 1: 40 in PBS/BSA/NaN3
buffer. After 45 min at 4°C in the dark the cells
were washed as before and then fixed in 1%
paraformaldehyde
in PBS/BSA/NaNj.
Finally,
the cells were washed, resuspended in 0.5 ml
PBS/BSA/NaNs and kept at 4°C in the dark until
fluorescence was analysed in a FACS IV (Becton
Dickinson, Mountain View, CA) flow cytometer.
Results are given as mean fluorescence intensity
per cell, relative to the autofluorescence
of
glutaraldehyde fixed chicken red blood cells as a
standard, in percent of the fluorescence obtained
with normal rabbit serum, and as the increase of
fluorescence peak channel number.
2.5. Immunoblotting
Plasma membrane enriched preparations of Raji
and AL 34 cells, obtained as described [19] were
denatured by boiling for 3 min in 3% SDS and 5%
,&mercaptoethanol
and subjected to gel electrophoresis on 10% polyacrylamide slab gels [20].
Molecular mass standards were analyzed on the
same gel. The proteins were electroblotted onto
nitrocellulose
filters (BA 85, Schleicher and
Schuell, Dassel, FRG) which were treated with 2%
gelatine in 50 mM Tris-saline (pH 7.4) containing
0.05% Tween 20 and kept at -20°C until antibody binding was tested. The part of the filter
containing the molecular mass standards was
stained with fast green. Filter strips were incubated
for 1 h at room temperature in rabbit sera or with
a mouse monoclonal antibody against HLA-DR ,f3
chain (DAKO, Copenhagen), all diluted 1: 100 in
Tris-saline containing 0.2% gelatine and 0.05%
Tween 20. The strips were washed in Tris-saline

with 0.05% Tween 20 and incubated with a
peroxidase-labelled second antibody, either swine
anti-rabbit immunoglobulin
serum (DAKO) or
anti-mouse
immunoglobulin
serum (DAKO),
followed by washing and staining with 0.5 g/l
4-chloro-1-naphthol
(Merck, Darmstadt)
and
0.01% hydrogen peroxide as substrates in 50 mM
sodium acetate buffer (pH 5.5). Antisera were absorbed with the synthetic peptides by incubation at
4°C overnight with undiluted sera to which the
respective peptides, dissolved in distilled water,
had bien added (1: 10, v/v). Absorbed sera were
diluted 1: 1oL) in Tris-saline immediately before
immunoblotting .
2.6. Isolation of IgG on protein A-Sepharose
Rabbit serum (1 ml) was applied to a column
packed with 1 ml protein A-Sepharose 4 B (Pharmacia, Uppsala) equilibrated in PBS. The column
was washed with at least 5 vols PBS, IgG eluted
with 0.05 M glycine buffer (pH 3.0) and 0.5 ml
fractions collected in test tubes containing 20 /cl of
1 M Tris for immediate neutralization. Fractions
containing protein were pooled, dialysed overnight
at 4°C against PBS, and tested for anti-peptide antibodies in the ELISA test.
3. RESULTS
3.1. Production of peptide specific antibodies
Analysis by ELISA (fig.1) showed that immunization
with the PTG coupled peptides
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Fig.1. ELISA of rabbit sera from animals immunized
with PTG-coupled peptides DQ(l-8) (no.1828, l ;
no.1829, 0), and DR(l-83 (no.1789, q ; no.1790, n)
respectively on microtiter plates coated with DQ(l-8)
(panel a), and DR(l-8) (panel b), respectively. Sera
tested were obtained after the 4th booster injection.
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Fig.2. Immunoblotting of plasma membrane enriched preparations from the cell lines Raji (panel a) and AL-34 (panel
b), incubated with a mouse monoclonal anti HLA-DR fi chain (DAKO) (lane A), normal rabbit sera (B), anti DQ(l-S),
no.1828 (C) and no.1829 (D), anti DR(l-8), no.1789 (E) and no.1790 (F), lanes G and H show incubation with IgG
from sera nos 1829 and 1790, respectively, purified on protein A-Sepharose. For details see section 2.
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Fig.3. Inhibition of antiserum binding to AL-34 membrane preparation by preincubation with free peptide. Filter strips
were incubated with antisera from rabbit no. 1829 (anti DQ(l-S), panel a, pretreated overnight with saline (lane l),
peptide DQ(l-8) at a final concentration of 0.1, 1.O and 5.0 mg/ml, respectively (lanes 2-4, respectively), and peptide
DR(l-8), at 5.0 mg/ml, respectively (lane 5). Panel b shows filter strips incubated with antisera from rabbit no.1790
(anti DR(l-8)) pretreated overnight with saline (lane l), peptide DQ(l-8) at 5 mg/ml (lane 2) and peptide DR(l-8)
at 0.1, 1.0 and 5.0 mg/ml, respectively (lanes 3-5). Final dilution of rabbit sera was 1: 100, for details see section 2.
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resulted in antibodies recognizing specifically the
amino acid sequence of the 2 different peptides. A
maximal titer was usually obtained after 3 booster
injections and remained constant for several
months (not shown). Pre-immune sera as well as
sera from animals immunized with PTG alone did
not bind to peptide coated plates. There was no
cross-reactivity detected when each antiserum was
tested at various dilutions on plates coated with the
other peptide (not shown). AI1 antisera showed
high titers, often greater than 1: 104, of PTG antibodies when tested on PTG coated plates (not
shown).
3.2. Detection of 29 kDa proteins
DQ( l-8) and DR( l-8) peptide antisera detected
29 kDa components in immunoblots of Raji and
AL-34 cell plasma membrane proteins separated
by SDS-gel electrophoresis (fig.2). Each peptide
was used to immunize 2 rabbits, and only one,
no. 1828, immunized with DQ(l-8), was not reac-

September 1985

tive with this band. The HLA-DR monoclonal antibody also detected a 29 kDa component (fig.2).
The binding of either N-terminal peptide antiserum was selectively inhibited in a dosedependent manner only by the peptide which was
used as antigen (fig.3). Protein A-Sepharose
purified IgG bound to a component of similar size
allowing detection of the 29 kDa component during the condition of a reduced background (fig.2).
3.3. Surface binding of peptide antisera
The antisera to both N-terminal peptides bound
to the surface of Raji and AL-34 cells known to express both HLA-DR and -DQ antigens (table 2).
The cell surface immunofluorescence
showed a
ring-shaped to dotted appearance and in experiments separate from those shown in table 2,
immunofluorescence
was discernible by both
microscopy and flow cytofluorometry in dilutions
ranging from 1: 100 to 1: 1000. When tested on
human peripheral blood mononuclear cells, the an-

Table 2
Flow cytometric analysis of rabbit antigen binding to living cells
Expt
no.

Relative fluorescence
Individual
1829 1789

NRS
(%)

1828

1
2
3
4
5

100

114
115
121
108
111

100
147
128
119
117

AL-34

1
2
3

100

250
100
111

Human peripheral
blood MC

1
2
3
4
5

100
100
100
100
100

Raji

Peak fluorescence channel number
Individual
1829 1789

1790

NRS

1828

100
109
106
126
102

133
308
174
192
154

0

0
0
0
0

4
3
5
3
13

0
21
8
7

0
4
3
12

38
48
17
16

11

13

28

433
133
106

375
143
110

283
161
143

0
0
0

15
0
21

35
6
0

42
4
0

24
21
34

128
140
140

147
139
138

nd
135
154

nd
176

0
0
0

13
16
14

20
16

nd
12

nd
19

151
138

120
120

129
109

0
0

23
17

10
13
25

12
16
23

19
21
23

170
134
141

1790

Cells (0.5 x 106/tube) were incubated with rabbit sera (final dilution 1: 100) and FITC-conjugated goat anti-rabbit
immunoglobulin sera, as described in section 2, and analysed in the FACS IV. Results are expressed as mean
fluorescence intensity per cell, calculated based on the autofluorescence of glutaraldehyde-fixed chicken red blood cells
( = 1.O),and expressed as percent of the value obtained with NRS ( = lOO%),or as increase in fluorescence peak channel
number (l-255) based on NRS (= 0), and corrected for the fluorescence peak of chicken red blood cells (= 100). All
samples were run in duplicates,
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Fig.4. Flow cytometric analysis of antisera binding to human peripheral blood mononuclear cells. Panel A shows a
and FITC fluorescence. Pointers indicate monocyte gating in FLS. Panel
B shows dual parameter analysis of the same sample. For details see section 2.

typical result for forward light scatter (FLS)

tisera bound primarily to cells defined by forward
light scatter to belong to larger cells which are consistent with the population
of monocytes,
and a

subpopulation
of lymphocytes
(fig.4). The binding
of the peptide antisera showed a similar intensity,
however, antiserum no. 1828 showed little binding.
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4. DISCUSSION
A variety of parameters have been claimed to be
of importance when chasing a peptide sequence for
antibody production. Among these, hydrophilicity
and probability of certain characteristics to determine secondary structure have been claimed to
determine the ability of a given peptide to elicit antibody binding to the same sequence in a protein
[8,9,21,22]. Also, a peptide length of around 14
amino acids was thought to be necessary to produce specific antibodies [21]. However, the present
study demonstrates that these constraints are not
always applicable, nor necessary. First, we used
the peptide antibody technique to make antibodies
against a given part of a polypeptide sequence,
determined rather by its uniqueness than its
hydrophilicity or amino acid composition. The important test was to determine whether it was possible to make antibodies against the N-terminal sequences of the HLA-DQ and -DR p chains, respectively. Such antibodies would be useful as markers
of a given subgroup of the family of HLA-D
region proteins. In the case of these HLA class II
antigens, the regions of interest are rather short,
and inclusion of longer stretches of homologous
sequences would increase the risk of obtaining
cross-reactive antisera. The peptides chosen by us
(table 1) were therefore by necessity selected
primarily due to their uniqueness of sequence, and
both peptides are only 8 amino acids long.
Yet, both peptides elicited production of antibodies which by the ELISA test proved to be sequence specific as they did not cross-react with
each other. Antisera against both peptides also
bound to a protein species of Mr 29000. The components detected corresponded to that recognized
by the monoclonal HLA class II fl chain antibody.
Although DQ and DR fl chains cannot be
distinguished by one-dimensional SDS-gel electrophoretic analysis and the lack of proof that
both antisera do not detect the same molecule, our
finding that there was a selective inhibition of
binding only by the peptide used for immunization
excludes the possibility of non-specific crossreactivity. Our results are consistent with the
possibility that 2 structurally distinct proteins of
the same apparent molecular mass were detected.
The antisera against the N-terminal peptide sequences also bound to the surface of living HLA
336
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class II positive transformed cells kept as continuous cell lines. In addition, and more importantly, the antisera also bound to the monocyte
and only part of the lymphocyte subpopulation of
human peripheral blood cells. Experiments with
double fluorescence showed no binding to Tlymphocytes
as defined by binding of the
monoclonal antibody Leu 1 (Beckton and Dickinson), which normally do not express class II antigens (not shown). The absence of binding to Tlymphocytes is a useful negative control with
respect to the specificity of our antisera.
Binding to living cells has so far been
demonstrated only in peptide antibodies against
the mouse thy-l antigens [9], and more recently
against HLA-DR fl chains [ 121. The latter peptides
were, however, chosen from a hydrophilic part of
the molecule showing extensive homology with
other DR and DQ polypeptides. These antisera
would therefore not be locus specific. The same
limitation would also be true for the study using
14-16-mer peptides to produce antibodies against
HLA-DR fl chains [ 111. These antibodies showed
reactivity
with denatured
proteins
on immunoblots, but not surface binding to living cells.
In contrast to these studies, our antisera are unique
since they, despite being raised against peptides of
only 8 amino acids in length, bind to their respective target proteins both in the native and
denatured state. We therefore conclude that the 2
sets of antisera should be useful as specific immunological reagents to detect expression of p
chain genes in the HLA-DQ and -DR loci.
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